MANH
Manhattan Associates, Inc.
MANH's outlook is improving, though it still trails on the overall score.
MU
Micron Technology, Inc.
MU has the edge over MANH overall, supported by stronger modeled upside and stronger valuation.
MANH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Strong |
MANH's revenue, profitability, cash flow and balance sheet are all currently healthy.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
MANH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 43x | $256 | — |
| Cheap | 52x | $187 | -27% |
| Fair | 72x | $257 | +0.3% |
| Current | 72x | $256 | — |
| Expensive | 88x | $312 | +22% |
Historical ranges are pointers, not guarantees.
MANH's PE is in its fair range at 72x. If earnings grow as analysts expect, today's price would be 43x next year's earnings, in its cheap range.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over MANH in the historical PE scenario, which offers more potential upside but is not a forecast.
MANH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MANH, with profitability improving.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
MANH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.01 | +68% |
| Q3 2026 | $3.57 | +1.7% |
| Q2 2026 | $3.49 | -2.5% |
| Q1 2026 | $3.57 | +2% |
| Q4 2025 | $3.60 | +2.6% |
| Q3 2025 | $3.51 | -0.3% |
| Q2 2025 | $3.58 | +9.1% |
| Q1 2025 | $3.50 | +14% |
| Q4 2024 | $3.51 | +24% |
MANH earned $3.57 per share over the past year, up 1.7% from the year before.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over MANH on earnings, with more consistent year-over-year improvement.
MANH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $306.2M | +11% |
| Q2 2026 | $297.8M | +9.3% |
| Q1 2026 | $282.2M | +7.4% |
| Q4 2025 | $270.4M | +5.7% |
| Q3 2025 | $275.8M | +3.4% |
| Q2 2025 | $272.4M | +2.7% |
| Q1 2025 | $262.8M | +3.2% |
| Q4 2024 | $255.8M | +7.4% |
MANH's revenue has grown year over year for 23 quarters in a row: $306M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | -1 points |
| Q2 2026 | 22% | -4.9 points |
| Q1 2026 | 23% | -1 points |
| Q4 2025 | 25% | +1.1 points |
| Q3 2025 | 27% | -0.7 points |
| Q2 2025 | 27% | +1.4 points |
| Q1 2025 | 24% | +1.4 points |
| Q4 2024 | 24% | -1 points |
MANH's operating margin was 26% last quarter, down 1 points from the same quarter a year ago.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over MANH on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over MANH on profitability, with a higher operating margin.
MANH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $67.6M | -22% |
| Q2 2026 | $89.7M | +28% |
| Q1 2026 | $79.9M | +7.5% |
| Q4 2025 | $142.4M | +40% |
| Q3 2025 | $87.2M | +42% |
| Q2 2025 | $70.1M | -1.4% |
| Q1 2025 | $74.4M | +42% |
| Q4 2024 | $101.6M | +18% |
MANH's free cash flow has been positive every quarter for seven years: $380M over the past year, up 14% from the year before.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over MANH on cash flow, with more consistent year-over-year improvement.
MANH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -265K shares |
| 1 year | -3.6% | -2.2M shares |
| 3 years | -5.7% | -3.6M shares |
| 5 years | -8.6% | -5.5M shares |
| Available history | -9.4% | -6.1M shares |
MANH has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $50.5M |
| Q2 2026 | $127.1M |
| Q1 2026 | $179.4M |
| Q4 2025 | $77M |
| Q3 2025 | $51.5M |
| Q2 2025 | $50.2M |
| Q1 2025 | $136.4M |
| Q4 2024 | $45.2M |
MANH spent $434M buying back its own shares over the past year, up 53% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
MANH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.7x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | -1.2x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
MANH has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
MANH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.2 | Overbought |
| Stochastic | 90.5 | Overbought |
MANH's weekly RSI is 74 (overbought) and its Stochastic is 90 (overbought).
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
MANH PE vs Technology Sector
| Metric | MANH | Sector median | Relative |
|---|---|---|---|
| PE | 72x | 28x | 158% above |
| PE % | 49 | 35 | 14 pts above |
MANH is trading at 72x earnings, a 158% premium to the Technology sector's median of 28x.
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over MANH on valuation relative to its sector.
MANH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $229.1 | 12% above |
| 20 week MA | $205.1 | 25% above |
| 50 week MA | $171.3 | 50% above |
| 100 week MA | $186.4 | 38% above |
| 200 week MA | $201.4 | 27% above |
MANH has the edge over MU on trend strength, trading above more of its moving averages.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 225% above its 200-week average.
MANH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $80.6 | $106.6 | +32% |
| 2021 | $106.6 | $155.3 | +46% |
| 2022 | $155.3 | $120.0 | -23% |
| 2023 | $120.0 | $215.3 | +80% |
| 2024 | $215.3 | $275.2 | +28% |
| 2025 | $275.2 | $176.4 | -36% |
| 2026 YTD | $176.4 | $256.4 | +45% |
MANH has finished higher in four of the last six years. It's up 45% so far in 2026.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over MANH on returns for 2026, with the stronger performance.